Find and Pitch Jounalists, Get Your Story Covered

Tags: biotechnology CRISPR drug development FDA Pharmaceuticals

	Profile	Recent Articles on Subject
1	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Biotechs emerging from stealth take aim at pharma’s prime targets - 26 days ago An Alzheimer’s drugmaker is accused of data ‘manipulation.’ Should its trials be stopped? - 7 months ago Astellas’ science chief on the leap into new technologies - about 1 year ago Red Jacket: Helen Sabzevari, an immunotherapy pioneer - over 1 year ago
2	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	How the race for the next obesity drug is shaping up - about 1 month ago The view from overseas on tumult in U.S. science - 2 months ago STAT+: Vertex drug for cystic fibrosis wins approval - 4 months ago The biotech news you need to read today - 5 months ago Versant enters obesity with new startup - 5 months ago Serum Institute of India wants government HPV contract - about 1 year ago Novartis reportedly decides to pass on Cytokinetics - over 1 year ago Novartis is building a new radioligand plant in China - over 1 year ago Johnson & Johnson antiviral pill for dengue shows early efficacy - over 1 year ago
3	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Capgemini unveils AI breakthrough to boost bioeconomy - 2 months ago Calluna Pharma completes successful phase 1 trial of new fibrotic disease drug - 6 months ago Poolbeg’s cytokine release syndrome drug shows potential - over 1 year ago
4	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Beyond GLP-1s? This biotech is exploring longer-term metabolic treatments - 2 months ago A biotech’s race to tackle the most severe hepatitis - 4 months ago In a Duchenne market beset by problems, Capricor data marks a bright spot - 9 months ago Kyverna follows oncology’s CAR-T cell playbook for an ultra-rare autoimmune disorder - 9 months ago 4 offbeat biotechs making a splash in the life sciences - 12 months ago
5	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Vertex Pharma Challenger Sionna Secures $191M in IPO Cash for Cystic Fibrosis Pipeline - 2 months ago Galapagos Keeps Focus on Cancer Cell Therapy, Spins Out Rest of Biz Into NewCo Backed by €2.4B - 3 months ago Gene-Editing Biotech Prime Medicine Strikes Up Cell Therapy R&D Alliance With Bristol Myers Squibb - 7 months ago Inflammation Biotech Alumis Trims IPO Plans But Still Raises $250M for Clinical Trials - 10 months ago
6	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: Galapagos to split itself into two companies as part of turnaround plan - 3 months ago
7	Natasha Lomas TechCrunch Journalist. Climber-in-training. Owns cats. Barcelona and London journalismclimbing	From pond scum to premium skincare? Deep Blue Biotech is all in on blue-green algae to make better chemicals - 5 months ago French cleantech startup Calyxia nets $35M to tackle microplastics pollution - 8 months ago
8	Michael Gibney Pharma Voice Teacher of English. Teacher of politics. Santiago, Chile educationpolitics	An RNA biotech draws the blueprint for a late-stage Dravet syndrome trial and beyond - 5 months ago Two former Alexion leaders fight through layoffs and a tough market to maintain a rare disease biotech - 5 months ago 2024 PharmaVoice 100s: Biotech Pathfinders - 6 months ago A plucky biotech threatening Pfizer’s grip on the Prevnar vaccine market - 8 months ago A biotech dousing ‘fires’ in the brain that plagued a bestselling author - 8 months ago A new biotech tackling IBD joins a race against Lilly and Gilead for a promising pill - 9 months ago Ex-Novartis exec sets out to create ‘Apple of AI’ - about 1 year ago This biotech aims to expand the CRISPR toolkit for more disease targets in the liver and brain - over 1 year ago A biotech tackles drug discovery with transcription factor know-how - over 1 year ago
9	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about ballooning 340B drug sales, Catalent reassuring customers, and more - 6 months ago STAT+: Pharmalittle: We’re reading about Novo buying Catalent, Amgen’s obesity drug, and more - about 1 year ago STAT+: Pharmalittle: Curevac loses key patent in battle with BioNTech; Abernethy to step down as Verily CMO - over 1 year ago STAT+: Pharmalittle: Weight loss drugs are being paired with bariatric surgery; Carl Icahn plans to oust Illumina directors - over 1 year ago STAT+: Pharmalittle: Bluebird claims big insurer will cover its sickle cell therapy; House Republicans threaten to subpoena FDA commish - over 1 year ago STAT+: Pharmalittle: U.K. approves world’s first CRISPR-based medicine; FDA to review pricey cancer drug lacking confirmatory data - over 1 year ago STAT+: Pharmalittle: Panel tells FDA that CRISPR sickle cell therapy is safe enough for patients; U.K. is urged to scrap IP demands in trade talks with India - over 1 year ago
10	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Tome Biosciences, once a high-flying gene-editing startup, is floundering - 8 months ago STAT+: Investors funnel $275 million into Paragon Therapeutics spinout - about 1 year ago STAT+: Immuno-oncology startup launches with $150 million, ex-Surface, Bluebird exec as CEO - about 1 year ago STAT+: Biotech FogPharma raises $145 million in anticipation of more clinical trials, pharma partnerships - about 1 year ago STAT+: Biotech launches with $135 million for Vertex-competing pain medicine - about 1 year ago STAT+: Biotech incubator Curie.Bio graduates its first startup - over 1 year ago

Journalists covering Calypso Biotech